Cargando…
Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
BACKGROUND: Type 2 (T2) high asthma is recognised as a heterogenous entity consisting of several endotypes; however, the prevalence and distribution of the T2 biomarkers in the general asthma population, across asthma severity, and across compartments is largely unknown. The objective of the present...
Autores principales: | Frøssing, Laurits, Klein, Ditte K., Hvidtfeldt, Morten, Obling, Nicolai, Telg, Gunilla, Erjefält, Jonas S., Bodtger, Uffe, Porsbjerg, Celeste |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026007/ https://www.ncbi.nlm.nih.gov/pubmed/36949964 http://dx.doi.org/10.1183/23120541.00483-2022 |
Ejemplares similares
-
Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD
por: Backer, Vibeke, et al.
Publicado: (2020) -
Missing sputum samples are common in asthma intervention studies and successful collection at follow-up is related to improvement in clinical outcomes
por: Frøssing, Laurits, et al.
Publicado: (2021) -
Mucosal cryobiopsies: a new method for studying airway pathology in asthma
por: Hvidtfeldt, Morten, et al.
Publicado: (2022) -
The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma
por: Frøssing, Laurits, et al.
Publicado: (2020) -
Bronchiectasis in severe asthma is associated with eosinophilic airway inflammation and activation
por: Frøssing, Laurits, et al.
Publicado: (2022)